The store will not work correctly when cookies are disabled.
Dimethyl-{2-[3-(4-propoxy-phenyl)-quinolin-2-ylsulfanyl]-ethyl}-amine hydrochloride
ID: ALA541554
PubChem CID: 13200254
Max Phase: Preclinical
Molecular Formula: C22H27ClN2OS
Molecular Weight: 366.53
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCOc1ccc(-c2cc3ccccc3nc2SCCN(C)C)cc1.Cl
Standard InChI: InChI=1S/C22H26N2OS.ClH/c1-4-14-25-19-11-9-17(10-12-19)20-16-18-7-5-6-8-21(18)23-22(20)26-15-13-24(2)3;/h5-12,16H,4,13-15H2,1-3H3;1H
Standard InChI Key: QKHGAVPSMAIURI-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
5.0929 1.1291 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 -1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9091 1.5019 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.9097 -3.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2071 -0.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2025 5.2568 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.5078 -3.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2093 -3.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5067 -1.5010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9067 3.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8096 -3.7478 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2049 3.7560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2404 5.8591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1622 5.8549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.1077 -2.9946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.4096 -3.7414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.4475 -3.1392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
2 4 1 0
4 5 2 0
3 6 1 0
5 7 1 0
6 7 1 0
4 8 1 0
2 9 1 0
8 10 1 0
8 11 2 0
10 14 2 0
13 14 1 0
11 15 1 0
13 15 2 0
9 16 1 0
13 17 1 0
12 18 1 0
16 18 1 0
6 19 2 0
7 20 2 0
12 21 1 0
12 22 1 0
17 23 1 0
23 24 1 0
24 25 1 0
19 26 1 0
20 27 1 0
26 27 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 366.53 | Molecular Weight (Monoisotopic): 366.1766 | AlogP: 5.34 | #Rotatable Bonds: 8 |
Polar Surface Area: 25.36 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 8.47 | CX LogP: 5.48 | CX LogD: 4.38 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.50 | Np Likeness Score: -1.12 |
References
1. Blackburn TP, Cox B, Guildford AJ, Le Count DJ, Middlemiss DN, Pearce RJ, Thornber CW.. (1987) Synthesis and 5-hydroxytryptamine antagonist activity of 2-[[2-(dimethylamino)ethyl]thio]-3-phenylquinoline and its analogues., 30 (12): [PMID:3681895] [10.1021/jm00395a013] |